• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Free fatty acid receptor 2 promotes cardiomyocyte hypertrophy by activating STAT3 and GATA4

    2022-11-28 13:19:26HuiGoKunmingTinXiojunFengMengqingYnChenGoYishengJingChenhoZhuHuzheZhuXuepingLiuYingfuPeng

    Hui Go*, Kunming Tin, Xiojun Feng, Mengqing Yn, Chen Go,Yisheng Jing, Chenho Zhu, Huzhe Zhu, Xueping Liu*, Yingfu Peng*

    a Department of Pharmacology, School of Medicine, Shaoxing University, Shaoxing 312000, China

    b Department of Pharmacology, School of Medicine, Jishou University, Jishou 416000, China

    c Department of Environmental Toxicity, Zunyi Medical University, Zunyi 563006, China

    d The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230002, China

    e Department of Pharmacology, School of Medicine, GuangXi University of science and Technology, Liuzhou 545006, China

    Keywords:

    FFA2

    Cardiac hypertrophy

    GATA4

    STAT3

    ERK1/2

    A B S T R A C T

    Free fatty acids (FFAs) play important roles in cardiovascular disease. Studies have shown that it is an important way for FAs to exert biological effects through their own receptors besides directly participating biochemical reaction in body. Free fatty acid receptor 2 (FFA2) can be activated by short-chain FAs and is involved in inflammatory reactions and lipid accumulation. Since the known pathological changes caused by FFA2 are also implicated in cardiac hypertrophy, we hypothesized that FFA2 might be pathogenic in cardiac hypertrophy. This paper showed that FFA2 expression significantly increased in cardiac hypertrophy in vivo and in vitro. FFA2 agonist 4-CMTB or TUG-1375 promoted the expression of the hypertrophy markers ANF and BNP and increased cell surface area in vitro, which was further strengthened by FFA2 overexpression,suggesting that FFA2 might contribute to cardiomyocyte hypertrophy. Furthermore, 4-CMTB treatment or FFA2 overexpression combined with 4-CMTB treatment elevated the phosphorylation and transcriptional activity of GATA4 and STAT3, which were inhibited by an ERK1/2 inhibitor, and GATA4 and STAT3 knockdown inhibited the elevation of hypertrophy biomarkers in cardiomyocytes treated with 4-CMTB. Taken together, these data indicate that FFA2 can enhance cardiomyocyte hypertrophy by activating STAT3 and GATA4 via ERK1/2, providing a potential new target for therapy.

    1. Introduction

    Cardiac hypertrophy describes adaptive changes in the heart caused by pressure overload, which is characterized by cardiomyocyte hypertrophy and interstitial fibrosis [1]. However,when hypertrophied, the heart is susceptible to ischemia caused by the increased ventricular wall thickness and diastolic dysfunction caused by fibrosis. Moreover, the systolic function of the heart is gradually impaired during disease progression, ultimately resulting in heart failure.

    Continuous activation of the sympathetic nervous system and the renin-angiotensin system play important roles in cardiac hypertrophy [1-4], and current drugs that improve outcomes for patients with cardiac hypertrophy or heart failure usually inhibit these two systems [2-4]. However, clinical outcomes are still unsatisfactory with these current therapies, and new drugs for cardiac hypertrophy are still needed.

    The role of fatty acids in cardiovascular disease such as atherosclerosis and cardiac hypertrophy has received increasing attention [5]. Interestingly, some studies have found that fatty acids not only participate in biochemical reactions in the body, but also function through their own receptors, free fatty acid (FFA) receptors [6-8].

    All FFA receptors are members of G protein-coupled receptors and mainly include FFA1 (GPR40), FFA2 (GPR43), FFA3 (GPR41)and FFA4 (GPR120); their natural ligands are FFAs with different carbon chain lengths [9,10]. FFA2 is 331 amino acid residues long and can be activated by short-chain fatty acids such as acetate, butyrate,and propionate. FFA2 is mainly expressed in the gastrointestinal tract,adipose tissue, immune cells, spleen, skeletal muscle, brain, etc., and there is a moderate expression in heart [11,12]. Previous studies have shown that FFA2 is associated with inflammatory reactions [13-15]and lipid accumulation [12], which play vital roles in cardiac hypertrophy. Moreover, FFA2 can couple with Gq/11and Giproteins,both of which may be related to cardiac hypertrophy: FFA2 reduces cAMP production through Gito regulate adenylate cyclase [9,10,13-15],which might impair cardiac contraction. Furthermore, FFA2 can elevate intracellular Ca2+and activate protein kinase C (PKC) and the mitogen-activated protein kinase (MAPK) cascade by activating Gq/11[16,17], and these changes are also closely related to cardiac hypertrophy [18,19].

    ERK1/2-MAPK is a downstream effector of FFA2 [16,17];furthermore, some transcription factors such as GATA4 and STAT3 can be activated by ERK1/2, which play important roles in cardiac hypertrophy [20,21]. So FFA2 might promote the transcription of hypertrophic genes and protein synthesis to induce cardiomyocyte hypertrophy by activating STAT3 and GATA4.

    2. Materials and methods

    2.1 Chemicals and antibodies

    4-CMTB (4642) was purchased from Tocris Bioscience (Bristol,UK). TUG-1375 was purchased from Target Molecule Corp.(Boston, MA, USA). Phenylephrine (PE, P6126) was obtained from Sigma Aldrich (St. Louis, MO, USA). U0126 (9903), rabbit monoclonal anti-p-MAPK-Erk1/2 (Thr202/Tyr204) (1:2 000; 4 370),rabbit monoclonal anti-p-STAT3 (Tyr705) (1:1 000; 9145), rabbit polyclonal anti-p-STAT3 (Ser727) (1:1 000; 9134), and mouse monoclonal anti-STAT3 (1:1 000; 9139) were purchased from Cell Signaling Technology (CST, Danvers, MA, USA). Isoproterenol(sc-202188), angiotensin II (sc-363643), rabbit polyclonal anti-FFA2 (1:100; sc-32906), mouse monoclonal anti-glyceraldehyde-3-phosphate dehydrogenase (1:200; GAPDH, sc-365062), mouse monoclonal anti-GATA4 (1:100; sc-25310), and mouse monoclonal anti-phospho-GATA4 (Ser262) (1:100; sc-377543) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Rabbit polyclonal anti-p-GATA4 (Ser105)(1:1 000; ab5245) was purchased from Abcam (Cambridge, UK).

    2.2 Animal model of cardiac hypertrophy

    Sprague-Dawley rats (male, 180-200 g) obtained from Hunan SJA Laboratory Animal Co., Ltd. (Changsha, China) were randomly divided into two groups: sham operation group (Sham) and abdominal aortic constriction (AAC) group. AAC surgery was performed to induce pressure overload as described previously [22]. Eight weeks after the operation, all rats were anaesthetized and then sacrificed for further experiments. All experimental procedures were conducted in conformity with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and approved by the Animal Care and Studies Committee of Jishou University (Jishou, China).

    2.3 Primary culture of neonatal rat cardiomyocytes (NRCMs)

    Primary cultures of NRCMs were prepared as described previously [23]. In brief, the chopped heart tissues of 1-2-day-old Sprague-Dawley rats were repeatedly digested with 0.08% trypsin at 37 °C for 10-12 times. The cells were collected by centrifugation at 800 r/min and re-suspended in DMEM with 10% newborn calf serum (NBCS). The cells were then incubated in culture flasks for 1 h at 37 °C in a humidified atmosphere with 5% CO2to remove adherent non-cardiomyocytes. The purified cardiomyocytes were cultured in DMEM supplemented with 10% NBCS and 0.1 mmol/L 5-bromodeoxyuridine for 16-24 h in 6-well plates (1.0 × 105cells/mL).Finally, the culture medium was replaced with fresh DMEM containing 10% NBCS. Before each experiment, cells were placed in serum-free medium for 16-18 h.

    2.4 RNA extraction and quantitative RT-PCR

    Total RNA was extracted using Trizol reagent (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. Total RNA was reverse transcribed to first-strand cDNA using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific). cDNA was amplified using KOD SYBR?qPCR Mix (Toyobo, Japan) in a real-time PCR machine (LightCycler,Roche, Penzberg, Germany). The primer sequences were were listed as follows: FFA2 (F: 5’-CCCGGTGCAGTACAAGCTAT-3’,R: 5’-C T G C T C G G T T G A G T T C A G G T-3’), A N F(F: 5’-C C G T A T A C A G T G C G G T G T C C-3’, R:5’-C A G A G A G G G A G C T A A G T G C C-3’), B N P(F: 5’-A G C T G C T T T G G G C A G A A G A T-3’, R:5’-AAAACAACCTCAGCCCGTCA-3’) and GAPDH(F: 5’-A G G A G T A A G A A A C C C T G G A C-3’, R:5’-CTGGGATGGAATTGTGAG-3’). Each PCR reaction was performed in triplicate. Data are presented as fold change over control group.

    2.5 RNA interference and plasmid transfection

    Cardiomyocytes were transfected with 2.5 μg FFA2 plasmid using 5 μL Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) in six-well plates according to the manufacturer’s instructions. ThepcDNA3.1-flag vector was used as a control. After transfection for 48 h, cells were harvested.

    Cardiomyocytes were transfected either with GATA4 siRNA or STAT3 siRNA with non-targeting siRNA (negative control,NC) using Lipofectamine 3000 according to the manufacturer’s instructions. siRNA sequences were: GATA4 siRNA (5’-CUUC AGAGCCGACAGCACUGGAUGG-3’) [24]and STAT3 siRNA(5’-GGCAUUCGGAAAGUAUUGUTT-3’) [25].

    2.6 Western blotting

    Cultured cardiomyocytes or cardiac tissues were homogenized in RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China)supplemented with protease inhibitor cocktail (sc-29130, Santa Cruz Biotechnology). The mixture was incubated on ice for 30 min and then centrifuged at 12 000 ×gfor 10 min at 4 °C and the total protein collected. Proteins were separated in 10% SDS–PAGE and were then transferred to PVDF membranes (Millipore, Burlington, MA,USA). Membranes were blocked with 5% bovine serum albumin and then incubated with primary antibodies overnight at 4 °C and secondary antibodies (1:5 000; Santa Cruz Biotechnology) for 1 h at room temperature. Blots were developed with an enhanced chemiluminescence substrate (Beyotime Biotechnology) and detected with the Minichemi 420 (Sage Creation Science Co., Ltd., Beijing,China). Blot intensities were quantified with the Image J software.

    2.7 Measurement of the cell surface area

    The cell surface area was determined by rhodamine-phalloidin staining as previously described [23]. Cardiomyocyte surface area (40 randomly chosen fields and 100 randomly chosen cells/field) was determined by Cellomics/High Content Screening (Thermo Fisher Scientific).

    2.8 Dual luciferase reporter gene assay

    ThepGATA4-TA-lucreporter plasmid, which contains the 2 600 bp 5’-flanking region of the ratANFgene, was constructed as described previously [26]. For the dual luciferase reporter assay,cardiomyocytes were seeded in 96-well culture plates and cotransfected with 100 ng ofpSTAT3-TA-lucreporter plasmid (Beyotime Biotechnology) orpGATA4-TA-lucreporter plasmid and 20 ng ofpRL-TKplasmid (Promega, Madison, WI, USA) using Lipofectamine 3 000 based on the manufacturer’s instructions. After 48 h, cells were lysed, and luciferase activity was determined using the dual luciferase reporter assay kit (Beyotime Biotechnology) according to the manufacturer’s recommendations. Luciferase activity was normalized to Renilla luciferase activity.

    2.9 Statistical analysis

    Data are expressed as mean ± S.D. Statistical analyses were performed using the unpaired Student’st-test or analysis of variance (ANOVA) followed by Bonferronipost hoctesting using SPSS 20.0 (IBM Statistics, Chicago, IL).P< 0.05 was considered statistically significant.

    3. Results

    3.1 FFA2 expression is elevated in cardiac hypertrophy

    AAC surgery was performed to induce cardiac hypertrophy in the rats. Compared with Sham rats, AAC rats had bigger hearts, thicker left ventricular walls, larger cardiomyocyte diameters (Fig. 1A), and higher heart-to-body weight ratios (Fig. 1B), indicating successful induction of cardiac hypertrophy. As shown Figs. 1C and 1D,compared to Sham rats, cardiac FFA2mRNA and protein expression were significantly increased in AAC rats.

    Next, NRCMs were treated with phenylephrine (PE), isoproterenol(ISO), or angiotensin II (Ang II) to induce cardiomyocyte hypertrophyin vitro. Gene expression of atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) (Fig. 2A) and the cell surface area(Fig. 2B) increased in cardiomyocytes treated with PE, ISO, or Ang II. ANF and BNP, which are secreted by atrial myocytes and ventricular myocytes respectively, rise in cardiac hypertrophy and are considered as important hypertrophic markers nowadays [1]. FFA2 mRNA (Fig. 2C) and protein (Fig. 2D) expression also increased after the treatments. Thus, FFA2 might play an important role in cardiac hypertrophy.

    Fig. 1 FFA2 expression increases in cardiac hypertrophy induced by AAC in rats. Rats underwent AAC or Sham surgery for 8 weeks. (A) H&E staining of transverse sections of hearts; scale bar = 50 μm; (B) heart-to-body weight ratio (HW/BW); (C) mRNA and (D) protein expression of FFA2 were detected by RT-PCR or western blotting, respectively. *P < 0.05 versus Sham.

    Fig. 2 FFA2 expression increases in cardiomyocyte hypertrophy induced by PE, ISO, or Ang II treatment in vitro. NRCMs were treated with or without PE(100 μmol/L), ISO (10 μmol/L), or Ang II (10 μmol/L) for 24 h. (A) mRNA expression of ANF and BNP was detected by RT-PCR (n = 4 independent experiments); (B) cell surface area was measured by phalloidin staining (n = 4 independent experiments); scale bar = 10 μm; (C) mRNA and(D) protein expression of FFA2 were detected by RT-PCR or western blotting, respectively (n = 5 independent experiments). *P < 0.05 versus Con.

    3.2 FFA2 promotes cardiomyocyte hypertrophy

    The increased expression of FFA2 might be associated with the development of cardiac hypertrophy. 4-CMTB, which is widely accepted as a specific FFA2 agonist that not only binds to both the orthosteric and the allosteric binding sites [27]but also activates Gqand Giproteins [17,28], or FFA2 overexpression to investigate the role of FFA2 in cardiomyocyte hypertrophy. As shown in Fig. 3, compared to control,ANFandBNPexpression and cell surface area increased in NRCMs treated with 4-CMTB. Compared to 4-CMTB treatment,these increases were even more obvious in FFA2-overexpressed NRCMs with 4-CMTB treatment (Figs. 3B and 3C). Moreover, the knockdown of FFA2 completely abolished the hypertrophic response in 4-CMTB-treated cardiomyocytes (Fig. 4), which indicated that it was a specific agonist for FFA2. To further enhance the reliability of our research, another FFA2 agonist, TUG-1375 [29]was used in this study. Similar results were obtained in cardiomyocytes treated with TUG-1375 (Figs. 3D and 3E). These results indicate that FFA2 can promote cardiomyocyte hypertrophy.

    Fig. 3 FFA2 promotes cardiomyocyte hypertrophy. NRCMs were transfected with pcDNA3.1-FFA2- flag plasmid or pcDNA3.1- flag for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) or TUG-1375 (10 μmol/L) for 24 h. (A) FFA2 protein expression was detected by western blotting; (B and D) mRNA levels of ANF and BNP were measured by RT-PCR; (C and E) cell surface area was measured by phalloidin staining; scale bar = 10 μm. *P < 0.05 versus pcDNA3.1,#P < 0.05 versus 4-CMTB or TUG-1375.

    Fig. 4 FFA2 knockdown inhibits cardiomyocyte hypertrophy induced by 4-CMTB. NRCMs were transfected with siRNA targeting FFA2 or NC for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for 24 h. (A) The expressions of FFA2 and p-ERK1/2 protein were detected by western blotting; (B) mRNA levels of ANF and BNP were measured by RT-PCR; (C) cell surface area was measured by phalloidin staining; scale bar = 10 μm. *P < 0.05 versus NC, #P < 0.05 versus 4-CMTB.

    3.3 GATA4 and STAT3 are involved in FFA2-induced cardiomyocyte hypertrophy

    Increased transcriptional activity of GATA4 plays a key role in cardiac hypertrophy, so we next studied the effects of GATA4 in FFA2-induced cardiomyocyte hypertrophy. Compared with control,4-CMTB treatment elevated GATA4 phosphorylation at Ser105(Fig. 5A) and GATA4 transcriptional activity (Fig. 5B) by western blotting and luciferase reporter assays, respectively, which were further increased inFFA2- flag plasmid-transfected cardiomyocytes.However, GATA4 phosphorylation at Ser262 was not altered by 4-CMTB treatment (Fig. 5A). In order to investigate whether GATA4 acts as a downstream signaling molecule of FFA2 in cardiomyocyte hypertrophy, we knocked downGATA4expression in cardiomyocytes treated with 4-CMTB (Fig. 5C). Compared to 4-CMTB treatment,GATA4knockdown significantly decreasedANFandBNPmRNA levels as well as cell surface area in cardiomyocytes stimulated with 4-CMTB, which might therefore inhibit cardiomyocyte hypertrophy(Figs. 5D and 5E).

    Fig. 5 GATA4 activation is involved in FFA2-induced cardiomyocyte hypertrophy. NRCMs were transfected with pcDNA3.1-FFA2- flag plasmid or pcDNA3.1- flag for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. (A) GATA4 phosphorylation at Ser105 and Ser262 as well as total GATA4 expression were detected by western blotting; (B) the transcriptional activity of GATA4 was measured using a luciferase reporter assay. *P < 0.05 versus pcDNA3.1, #P < 0.05 versus 4-CMTB. To investigate the role of GATA4 in FFA2-induced cardiomyocyte hypertrophy, NRCMs were transfected with siRNA targeting GATA4 or NC for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. (C) Western blotting was used to evaluate the silencing efficacy of siRNA targeting GATA4; (D) ANF and BNP mRNA levels as well as (E) cell surface area were measured to assess the hypertrophic responses; scale bar = 10 μm. *P < 0.05 versus NC, #P < 0.05 versus 4-CMTB.

    STAT3 is another important transcription factor involved in cardiac hypertrophy. We found that STAT3 phosphorylation at Tyr705 and Ser727 (Fig. 6A) as well as its transcriptional activity(Fig. 6B) were elevated by 4-CMTB compared to control, and these changes were more obvious in 4-CMTB-treated cardiomyocytes after transfection withFFA2- flag plasmid (Figs. 6A and 6B). To investigate the role of STAT3 as a downstream signaling molecule of FFA2 in cardiomyocyte hypertrophy, we knocked downSTAT3expression in cardiomyocytes treated with 4-CMTB (Fig. 6C). Compared to 4-CMTB treatment alone,STAT3knockdown significantly decreasedANFandBNPmRNA expression as well as cell surface area in cardiomyocytes stimulated with 4-CMTB (Figs. 6D and 6E), thereby inhibiting cardiomyocyte hypertrophy.

    Fig. 6 STAT3 activation is involved in FFA2-induced cardiomyocyte hypertrophy. NRCMs were transfected with pcDNA3.1-FFA2- flag plasmid or pcDNA3.1-lf ag for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. (A) NRCMs were transfected with FFA2- flag plasmid or pcDNA3.1 for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. STAT3 phosphorylation at Tyr705 and Ser727 as well as total STAT3 expression were detected by western blotting; (B) the transcriptional activity of STAT3 was measured using a luciferase reporter assay. *P < 0.05 versus vector, #P < 0.05 versus 4-CMTB. To investigate the role of STAT3 in FFA2-induced cardiomyocyte hypertrophy, NRCMs were transfected with siRNA targeting STAT3 or NC for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. (C) Western blotting was used to evaluate the silencing efficacy of siRNA targeting STAT3; (D) ANF and BNP mRNA expression as well as (E) cell surface area were measured to assess hypertrophic responses; scale bar = 10 μm. *P < 0.05 versus NC, #P < 0.05 versus 4-CMTB.

    ERK1/2 can promote the phosphorylation of GATA4 at Ser105 and STAT3 at Ser727 [20,21]. U0126, a MAPK-ERK1/2 pathway inhibitor [30](Fig. 7A), reduced GATA4 phosphorylation at Ser105(Fig. 7B) as well as GATA4 transcriptional activity (Fig. 7C)in cardiomyocytes treated with 4-CMTB. In addition, STAT3 phosphorylation at Ser727 (Fig. 7D) as well as its transcriptional activity (Fig. 7E) were also inhibited by U0126. Furthermore,increases inANFandBNPmRNA expression as well as cell surface area induced by 4-CMTB treatment were also reduced by U0126 treatment (Figs. 7F and 7G). Similar results were observed in cardiomyocytes treated with TUG-1375 (Fig. 8).

    Fig. 7 The effects of 4-CMTB on GATA4 and STAT3 function as well as cardiomyocyte hypertrophy are impaired by MAPK-ERK1/2 pathway inhibition.NRCMs were stimulated with or without 4-CMTB (10 μmol/L) and simultaneously treated with or without U0126 (10 μmol/L) for 24 h. (A) p-ERK1/2,(B) p-GATA4 at Ser105, and (D) p-STAT3 at Tyr705 and Ser727 expression were detected by western blotting; the transcriptional activities of (C) GATA4 and (E) STAT3 were measured using a luciferase reporter assay; the mRNA levels of (F) ANF and BNP as well as (G) cell surface area were measured to assess hypertrophic responses; scale bar = 10 μm. *P < 0.05 versus Con, #P < 0.05 versus 4-CMTB.

    Fig. 8 The effects of TUG-1375 on GATA4 and STAT3 function as well as cardiomyocyte hypertrophy are impaired by MAPK-ERK1/2 pathway inhibition.NRCMs were stimulated with or without TUG-1375 (10 μmol/L) and simultaneously treated with or without U0126 (10 μmol/L) for 24 h. (A) p-GATA4 at Ser105, and (C) p-STAT3 at Ser727 expression were detected by western blotting; the transcriptional activities of (B) GATA4 and (D) STAT3 were measured using a luciferase reporter assay; the mRNA levels of (E) ANF and BNP as well as (F) cell surface area were measured to assess hypertrophic responses;scale bar = 10 μm. *P < 0.05 versus Con, #P < 0.05 versus 4-CMTB.

    4. Discussion

    Heart failure remains a serious public health challenge, and inhibiting the development or reducing the severity of cardiac hypertrophy is important for the improved prevention and treatment of heart failure. FFA2 is a physiological protein involved in immune responses, insulin secretion, and energy metabolism [10].Additionally, FFA2 has been associated with inflammation [13-15]and lipid accumulation [12], although its exact role in these pathological processes remains uncertain and sometimes contradictory [31,32]. It should be noted that chronic inflammation and disorders of lipid metabolism are often observed during cardiac hypertrophy [1,33]. Therefore, whether FFA2 mediates cardiac hypertrophy aroused our interest. Here we found that FFA2 expression increasedin vitroandin vivoin a cardiomyocyte hypertrophy model (Figs.1 and 2). Specific agonist or FFA2 overexpression with agonist elevatedANFandBNPexpression as well as the cell surface area, ultimately inducing cardiomyocyte hypertrophyin vitro(Fig. 3). Simultaneously,FFA2 overexpression alone could not induce cardiomyocyte hypertrophyin vitro, which was probably due to the lack of natural ligands in culture medium. In addition, we found that the band of FFA2 was obviously shifted up and has a large molecular weight span from 55 kDa to over 180 kDa in western blot analysis, which might be associated with the heavy glycosylation of FFA2 [34]. The glycosylation modification is ubiquitous in GPCRs [35]and can cause the bands to move up significantly in SDS-PAGE electrophoresis [36,37].

    It is intriguing how FFA2 induces cardiac hypertrophy. GATA4 and STAT3 are two key transcription factors implicated in cardiac hypertrophy, and phosphorylation plays important roles in their activation. GATA4 is essential in heart development becauseGATA4knockout caused the death of mice at early embryonic stages [38,39].On the other hand,GATA4transgenic mice showed significant cardiac hypertrophy [40]. Furthermore GATA4 promotes the transcription of hypertrophic genes such asβ-myosin heavy chain,ANF, BNP and so on in response to hypertrophic stimulation [21].Two key phosphorylation sites are responsible for GATA4 activation.The phosphorylation at S105 promotes its DNA binding activity and increases the expression of its target genes; moreover, the phosphorylation at S262 induces interaction with p300 and then result in GATA4 acetylation and activation [21]. We found that 4-CMTB significantly induced phosphorylation of GATA4 at Ser105 as well as its transcriptional activity, which were further reinforced by FFA2 overexpression (Figs. 5A and 5B). Moreover,GATA4knockdown rescued 4-CMTB-induced cardiomyocyte hypertrophy(Figs. 5D and 5E). Similarly, STAT3 is involved in models of cardiac hypertrophy such as pressure overload [41,42]and in Ang II type 1 receptor transgenic mice [43]. Furthermore, cardiomyocytespecificSTAT3transgenic mice showed spontaneous cardiac hypertrophy [44]; conversely, inhibition of STAT3 alleviated cardiac hypertrophy [41,45,46]. It has also been shown that activation of FFA2 increases the phosphorylation of STAT3 at Tyr705 and expression of its target genes [47-49]. The phosphorylation at Tyr705 facilitates its homo/hetero-dimerization and is essential for DNA binding; in addition, STAT3 at Ser727 can be also phosphorylated for obtaining maximal transcriptional activity [20]. In the present study,we found that STAT3 phosphorylation at Tyr705 and Ser727 as well as STAT3 transcriptional activity increased after treatment with 4-CMTB (Figs. 6A and 6B). Moreover, cardiomyocyte hypertrophy induced by 4-CMTB treatment was attenuated bySTAT3knockdown(Figs. 6D and 6E). Hence, abnormal activation of GATA4 and STAT3 appear to participate in FFA2-meditated cardiomyocyte hypertrophy.

    Both GATA4 at Ser105 and STAT3 at Ser727 are phosphorylated by MAPK-ERK1/2 [20,21]. ERK1/2 is a downstream target of FFA2 that can be used to evaluate FFA2 activity [16,50]. We found that U0126, a MAPK-ERK1/2 pathway inhibitor, reduced phosphorylation levels of GATA4 at Ser105 and STAT3 at Tyr705 in 4-CMTB-treated cardiomyocytes (Figs. 7A and 7B). These results indicate that ERK1/2 is likely to mediate the increase in GATA4 and STAT3 transcriptional activity by FFA2. In addition, STAT3 phosphorylation at Tyr705 could not be inhibited by U0126, which indicates this site cannot be phosphorylated by ERK1/2. This post-translational modification of STAT3 might be related to FFA2-mediated release of inflammatory factors such as IL-6 [14,51]and TNF-α [52].

    It is generally considered that the ERK1/2 signaling pathway promotes cardiac hypertrophy. For instance, constitutively ERK1/2 activation in the heart induced cardiac hypertrophy in MEK1(upstream of ERK1/2) transgenic mice [53]. On the contrary, the inhibition of ERK1/2 signaling ameliorated cardiac hypertrophy[30,33]. FFA2 can induce the activation of ERK1/2 through both Giand Gqsignaling, but Gqpathway might be predominant [50].Furthermore, ERK1/2 autophosphorylation at Thr188 site via Gqsignaling triggered its nuclear localization and phosphorylation of target proteins and then promoted cardiac hypertrophy. Therefore, it is a possible way for the activation of GATA4 and STAT3 induced by FFA2 via ERK1/2. However, the inhibition of ERK1/2 by U0126 could not completely abolish the hypertrophy induced by FFA2, as did the knockdown of GATA4 or STAT3, which indicated that other pathways such as Ca2+-mediated signaling and PKC [54]might were involved in this pathological process.

    It should be noted that although short-chain fatty acids (SCFAs)such as acetate, butyrate, and propionate are natural ligands for FFA2, SCFAs can exert their functions via both FFA2-dependent and independent mechanisms. For example, SCFAs can activate FFA3 or enter the cytoplasm to inhibit histone deacetylase [55,56]and SIRT3 [57], which might lead to inconsistent results; so high selective agonists are needed in the study of FFA2. It may be worthy to explore the selective agonists in the natural food.

    In summary, FFA2 might promote cardiomyocyte hypertrophy through activation of STAT3 and GATA4 via ERK1/2. Our results provide new insights into the role of FFA2 in cardiac biology and suggest that further studies of it as a therapeutic target in cardiac hypertrophy and heart failure are warranted. Since FFA2 contains two ligand-binding sites and can couple to different G proteins, and FFA2 is widely involved in the regulation of physiological functions and pathological processes, so further investigation of the specificity of downstream signaling events in different diseases and under different inhibitory conditions are required.

    Conflicts of interest

    The authors declare no conflict of interest.

    Acknowledgments

    This work was supported by the National Natural Science Foundation of China (No. 81760058, 81560059, 81660042,31800891), the Scientific Research Project of Health and Family Planning Commission of Hunan Province (No. C2017025), the Project of Medical and Health Science and Technology of Shaoxing City(No. 2020A13063) and the Startup Fund for Research of Shaoxing University (No. 20205021).

    亚洲美女黄片视频| 久久久色成人| 日本与韩国留学比较| 手机成人av网站| 亚洲在线自拍视频| 三级毛片av免费| 99在线视频只有这里精品首页| 嫩草影院入口| 国产国拍精品亚洲av在线观看 | 91av网一区二区| 少妇熟女aⅴ在线视频| 怎么达到女性高潮| 精品久久久久久久久久免费视频| 免费人成在线观看视频色| 国产激情偷乱视频一区二区| 中文字幕高清在线视频| 精品福利观看| 日本黄大片高清| 18禁黄网站禁片免费观看直播| 一二三四社区在线视频社区8| 久久久久久久久大av| 国产蜜桃级精品一区二区三区| 成人三级黄色视频| 亚洲精品在线观看二区| 欧美日本亚洲视频在线播放| 男女做爰动态图高潮gif福利片| 色吧在线观看| 亚洲精品国产精品久久久不卡| 十八禁网站免费在线| 一二三四社区在线视频社区8| 久久久久久大精品| 亚洲熟妇熟女久久| 他把我摸到了高潮在线观看| 国产三级中文精品| 日韩精品中文字幕看吧| 最近最新中文字幕大全电影3| 波多野结衣巨乳人妻| 特大巨黑吊av在线直播| 一本久久中文字幕| 国产一区二区三区在线臀色熟女| 日韩欧美三级三区| 人人妻,人人澡人人爽秒播| 国产黄片美女视频| 日韩欧美在线乱码| 精品久久久久久久久久久久久| 97超级碰碰碰精品色视频在线观看| 国产老妇女一区| 国产精品久久久久久久久免 | 激情在线观看视频在线高清| 国产探花在线观看一区二区| 午夜福利成人在线免费观看| av片东京热男人的天堂| 日韩高清综合在线| or卡值多少钱| 亚洲激情在线av| 午夜免费观看网址| av天堂在线播放| 99视频精品全部免费 在线| 中文字幕av在线有码专区| 国产成人啪精品午夜网站| 欧美日韩福利视频一区二区| 日本免费a在线| 宅男免费午夜| 午夜福利在线在线| 九九在线视频观看精品| 在线天堂最新版资源| 天堂av国产一区二区熟女人妻| 午夜久久久久精精品| 午夜激情欧美在线| 丝袜美腿在线中文| 性色av乱码一区二区三区2| 有码 亚洲区| 搡老岳熟女国产| 国产精品电影一区二区三区| 欧美极品一区二区三区四区| 九色国产91popny在线| 小蜜桃在线观看免费完整版高清| 国产乱人伦免费视频| 免费在线观看影片大全网站| 日本熟妇午夜| 小蜜桃在线观看免费完整版高清| 91九色精品人成在线观看| 亚洲天堂国产精品一区在线| 亚洲一区高清亚洲精品| 99久久综合精品五月天人人| 成人鲁丝片一二三区免费| 国产av一区在线观看免费| 日日摸夜夜添夜夜添小说| 午夜日韩欧美国产| 天天一区二区日本电影三级| 欧美日韩瑟瑟在线播放| 成人欧美大片| 国产探花极品一区二区| 久久久久免费精品人妻一区二区| 免费观看精品视频网站| 校园春色视频在线观看| 久久久国产成人精品二区| 国产视频内射| 免费看日本二区| 精品日产1卡2卡| 午夜激情福利司机影院| 亚洲人成伊人成综合网2020| 欧洲精品卡2卡3卡4卡5卡区| 亚洲一区高清亚洲精品| 免费在线观看成人毛片| 欧美色视频一区免费| 久久久国产成人免费| 国产精品永久免费网站| 在线国产一区二区在线| 成人永久免费在线观看视频| 欧美乱码精品一区二区三区| 高潮久久久久久久久久久不卡| xxx96com| 国产精品久久久久久久久免 | 国产高清激情床上av| 亚洲美女视频黄频| 亚洲内射少妇av| a在线观看视频网站| 欧美另类亚洲清纯唯美| 欧美一级a爱片免费观看看| 成人高潮视频无遮挡免费网站| 午夜福利在线观看免费完整高清在 | 香蕉久久夜色| 99久久久亚洲精品蜜臀av| 欧美日本亚洲视频在线播放| 国产国拍精品亚洲av在线观看 | 午夜精品一区二区三区免费看| 韩国av一区二区三区四区| 国产精品久久久久久久电影 | 偷拍熟女少妇极品色| 超碰av人人做人人爽久久 | 久久精品国产99精品国产亚洲性色| 高清在线国产一区| 国产亚洲精品综合一区在线观看| 中文字幕av在线有码专区| 国产伦在线观看视频一区| 99国产精品一区二区三区| 麻豆成人午夜福利视频| 给我免费播放毛片高清在线观看| 少妇的丰满在线观看| 一级毛片女人18水好多| 一级黄色大片毛片| 麻豆久久精品国产亚洲av| 午夜福利18| 国产成年人精品一区二区| а√天堂www在线а√下载| 国产精品久久视频播放| 美女 人体艺术 gogo| 91麻豆av在线| 国产激情偷乱视频一区二区| 九九在线视频观看精品| 亚洲乱码一区二区免费版| 精品国产三级普通话版| 亚洲无线在线观看| 午夜免费激情av| 国产在视频线在精品| 亚洲专区国产一区二区| 亚洲精品一区av在线观看| 88av欧美| 狠狠狠狠99中文字幕| 午夜精品在线福利| 国产日本99.免费观看| 国产又黄又爽又无遮挡在线| 亚洲最大成人中文| 99视频精品全部免费 在线| 身体一侧抽搐| 久久精品人妻少妇| 亚洲成人中文字幕在线播放| 97人妻精品一区二区三区麻豆| 久久久久久久久大av| 十八禁网站免费在线| 欧美性感艳星| 日本免费a在线| 欧美成人a在线观看| 18禁裸乳无遮挡免费网站照片| 久久久色成人| 精品无人区乱码1区二区| 蜜桃亚洲精品一区二区三区| 丰满人妻熟妇乱又伦精品不卡| 九色国产91popny在线| 免费人成在线观看视频色| 日日摸夜夜添夜夜添小说| 天天一区二区日本电影三级| 波野结衣二区三区在线 | 婷婷精品国产亚洲av在线| 亚洲精品日韩av片在线观看 | 中国美女看黄片| av女优亚洲男人天堂| 老司机午夜十八禁免费视频| 法律面前人人平等表现在哪些方面| 窝窝影院91人妻| 亚洲欧美日韩东京热| 在线观看66精品国产| 日韩人妻高清精品专区| 人人妻人人澡欧美一区二区| 亚洲片人在线观看| 88av欧美| 叶爱在线成人免费视频播放| 亚洲aⅴ乱码一区二区在线播放| 国模一区二区三区四区视频| 久久性视频一级片| 女警被强在线播放| 国产高清三级在线| 亚洲av二区三区四区| 亚洲精品成人久久久久久| 男女之事视频高清在线观看| 欧美色欧美亚洲另类二区| 国产亚洲精品综合一区在线观看| 国产高清视频在线播放一区| 国产成年人精品一区二区| 精品久久久久久久末码| 99热这里只有精品一区| 国产伦在线观看视频一区| 亚洲精品日韩av片在线观看 | 51国产日韩欧美| 欧美日韩国产亚洲二区| 色噜噜av男人的天堂激情| 欧美xxxx黑人xx丫x性爽| 欧美中文综合在线视频| 国产午夜精品论理片| 99国产极品粉嫩在线观看| 一二三四社区在线视频社区8| 午夜福利在线观看吧| 久久伊人香网站| 久久精品国产亚洲av涩爱 | xxx96com| 欧美区成人在线视频| 神马国产精品三级电影在线观看| 久久这里只有精品中国| 日本a在线网址| 成年免费大片在线观看| 国产成人av激情在线播放| 小说图片视频综合网站| 九九久久精品国产亚洲av麻豆| 搡老妇女老女人老熟妇| 国内精品久久久久久久电影| 窝窝影院91人妻| 麻豆久久精品国产亚洲av| 免费电影在线观看免费观看| 欧美zozozo另类| 国产日本99.免费观看| 成人一区二区视频在线观看| 亚洲精品一卡2卡三卡4卡5卡| 国产野战对白在线观看| 国产一区二区激情短视频| 午夜福利视频1000在线观看| 91麻豆av在线| 757午夜福利合集在线观看| 国产精品1区2区在线观看.| 尤物成人国产欧美一区二区三区| 免费无遮挡裸体视频| 91av网一区二区| 日本a在线网址| 最新在线观看一区二区三区| 窝窝影院91人妻| 村上凉子中文字幕在线| 97超视频在线观看视频| 国模一区二区三区四区视频| 欧洲精品卡2卡3卡4卡5卡区| 又紧又爽又黄一区二区| 久久婷婷人人爽人人干人人爱| 国产精品久久视频播放| 色尼玛亚洲综合影院| 一个人观看的视频www高清免费观看| 日韩有码中文字幕| 欧美绝顶高潮抽搐喷水| 国产欧美日韩一区二区三| 亚洲人成伊人成综合网2020| 9191精品国产免费久久| 婷婷六月久久综合丁香| 亚洲最大成人手机在线| 亚洲欧美日韩高清在线视频| 久久精品人妻少妇| 欧美zozozo另类| 午夜视频国产福利| 国产真人三级小视频在线观看| 午夜精品在线福利| 少妇的逼水好多| 一a级毛片在线观看| 精品一区二区三区视频在线 | 成人av一区二区三区在线看| 香蕉丝袜av| 亚洲欧美激情综合另类| 欧美+日韩+精品| 2021天堂中文幕一二区在线观| 欧美一区二区亚洲| 黄色丝袜av网址大全| 日韩精品青青久久久久久| 少妇裸体淫交视频免费看高清| 国产色爽女视频免费观看| 91久久精品电影网| 亚洲av成人av| 真人一进一出gif抽搐免费| 国产伦一二天堂av在线观看| 美女高潮喷水抽搐中文字幕| 精品日产1卡2卡| 免费在线观看影片大全网站| 亚洲欧美日韩卡通动漫| 免费观看精品视频网站| 日韩欧美精品v在线| 久久性视频一级片| 99久久精品一区二区三区| 色在线成人网| 香蕉丝袜av| 一卡2卡三卡四卡精品乱码亚洲| 欧美精品啪啪一区二区三区| 国产欧美日韩一区二区三| 高清毛片免费观看视频网站| 两个人看的免费小视频| 亚洲中文字幕一区二区三区有码在线看| 岛国视频午夜一区免费看| 男人的好看免费观看在线视频| xxx96com| 91久久精品电影网| 久久久精品欧美日韩精品| 亚洲天堂国产精品一区在线| 国产亚洲精品久久久久久毛片| 欧美一区二区亚洲| 精品人妻一区二区三区麻豆 | 亚洲avbb在线观看| 亚洲人成网站在线播放欧美日韩| 国产主播在线观看一区二区| 国产精品综合久久久久久久免费| 国产av不卡久久| 可以在线观看的亚洲视频| 中文资源天堂在线| 亚洲欧美日韩无卡精品| 日本a在线网址| 亚洲精品乱码久久久v下载方式 | 亚洲av成人av| 国产美女午夜福利| 亚洲国产日韩欧美精品在线观看 | 操出白浆在线播放| 久久久精品大字幕| 身体一侧抽搐| 美女高潮喷水抽搐中文字幕| 日本一二三区视频观看| 九色国产91popny在线| 人人妻,人人澡人人爽秒播| 亚洲国产欧洲综合997久久,| 国产欧美日韩一区二区精品| 搡老熟女国产l中国老女人| 国产一区在线观看成人免费| 亚洲最大成人手机在线| 久久精品国产亚洲av涩爱 | 女同久久另类99精品国产91| 女生性感内裤真人,穿戴方法视频| 性欧美人与动物交配| 日本熟妇午夜| 岛国视频午夜一区免费看| 欧美日韩福利视频一区二区| netflix在线观看网站| 久久国产乱子伦精品免费另类| 欧美黑人巨大hd| 国产aⅴ精品一区二区三区波| 神马国产精品三级电影在线观看| 久久久久久久精品吃奶| 一级毛片女人18水好多| 美女免费视频网站| 亚洲精华国产精华精| 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 国产成人aa在线观看| 亚洲午夜理论影院| 丰满人妻一区二区三区视频av | 国产aⅴ精品一区二区三区波| 国产成人系列免费观看| 男插女下体视频免费在线播放| 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 亚洲男人的天堂狠狠| 免费看光身美女| 国产91精品成人一区二区三区| 亚洲一区高清亚洲精品| 老司机在亚洲福利影院| 国产黄a三级三级三级人| 夜夜爽天天搞| 欧美丝袜亚洲另类 | 一个人免费在线观看的高清视频| 亚洲av不卡在线观看| 亚洲 欧美 日韩 在线 免费| 一个人免费在线观看的高清视频| 国产av一区在线观看免费| 99久久久亚洲精品蜜臀av| 超碰av人人做人人爽久久 | 成人国产综合亚洲| 国产精品自产拍在线观看55亚洲| 午夜久久久久精精品| 中文字幕人成人乱码亚洲影| 女警被强在线播放| 亚洲国产精品合色在线| 亚洲国产欧洲综合997久久,| 国产精品亚洲av一区麻豆| 日本黄色视频三级网站网址| 18禁在线播放成人免费| 午夜久久久久精精品| 精品电影一区二区在线| 18美女黄网站色大片免费观看| 国产午夜精品论理片| 丰满人妻一区二区三区视频av | 午夜精品一区二区三区免费看| 大型黄色视频在线免费观看| 少妇裸体淫交视频免费看高清| 欧美日韩亚洲国产一区二区在线观看| 国产精品1区2区在线观看.| 免费电影在线观看免费观看| 亚洲人成电影免费在线| 在线十欧美十亚洲十日本专区| 88av欧美| 成人av在线播放网站| 在线十欧美十亚洲十日本专区| 久久精品国产亚洲av香蕉五月| 久9热在线精品视频| 成人国产综合亚洲| 香蕉av资源在线| 热99re8久久精品国产| 国产黄片美女视频| 淫秽高清视频在线观看| 亚洲久久久久久中文字幕| 欧美三级亚洲精品| 中文字幕熟女人妻在线| www国产在线视频色| 亚洲人成网站在线播放欧美日韩| 有码 亚洲区| 老司机福利观看| 国产精品98久久久久久宅男小说| 亚洲激情在线av| 成人性生交大片免费视频hd| 欧美高清成人免费视频www| 中文字幕人成人乱码亚洲影| 十八禁人妻一区二区| 丁香六月欧美| 亚洲精品成人久久久久久| 热99re8久久精品国产| 欧美乱色亚洲激情| 亚洲美女黄片视频| 免费观看的影片在线观看| 亚洲成av人片在线播放无| 国产伦精品一区二区三区视频9 | 熟女少妇亚洲综合色aaa.| 久久精品91蜜桃| 深爱激情五月婷婷| 黄色丝袜av网址大全| 国产精品综合久久久久久久免费| 亚洲欧美日韩卡通动漫| 久久久久久久久中文| 深夜精品福利| 黄色片一级片一级黄色片| 国产精品99久久久久久久久| 黄色女人牲交| 狂野欧美白嫩少妇大欣赏| 老熟妇乱子伦视频在线观看| 亚洲,欧美精品.| 欧美中文日本在线观看视频| 欧美日韩黄片免| 午夜亚洲福利在线播放| 夜夜躁狠狠躁天天躁| 亚洲精品成人久久久久久| 给我免费播放毛片高清在线观看| 亚洲无线观看免费| 香蕉av资源在线| 又爽又黄无遮挡网站| 欧美一区二区精品小视频在线| 狠狠狠狠99中文字幕| 免费在线观看日本一区| av国产免费在线观看| 麻豆国产av国片精品| 黄色成人免费大全| 中文字幕熟女人妻在线| 免费在线观看日本一区| 国产精品,欧美在线| 亚洲第一欧美日韩一区二区三区| 亚洲人成网站在线播放欧美日韩| 亚洲精品影视一区二区三区av| 熟妇人妻久久中文字幕3abv| 免费av毛片视频| 美女高潮的动态| 亚洲专区中文字幕在线| 午夜免费激情av| 亚洲国产精品合色在线| 乱人视频在线观看| 看黄色毛片网站| 国产欧美日韩精品亚洲av| 最新美女视频免费是黄的| 国产精品香港三级国产av潘金莲| 午夜精品久久久久久毛片777| 黄色日韩在线| 成年女人永久免费观看视频| 老师上课跳d突然被开到最大视频 久久午夜综合久久蜜桃 | 免费人成在线观看视频色| 国产蜜桃级精品一区二区三区| 国产精品久久久久久久久免 | 久久久久免费精品人妻一区二区| 国产一区二区激情短视频| 精品一区二区三区av网在线观看| 久久人人精品亚洲av| 亚洲真实伦在线观看| 淫秽高清视频在线观看| 人妻丰满熟妇av一区二区三区| 一a级毛片在线观看| 精品久久久久久久末码| 高潮久久久久久久久久久不卡| eeuss影院久久| 女人被狂操c到高潮| 男人舔奶头视频| 国产成人aa在线观看| 欧美日韩精品网址| 91在线精品国自产拍蜜月 | 亚洲成人中文字幕在线播放| 亚洲成人久久爱视频| av天堂中文字幕网| 亚洲精华国产精华精| 欧美日韩瑟瑟在线播放| 免费大片18禁| 亚洲午夜理论影院| 色综合站精品国产| 高清在线国产一区| www日本黄色视频网| 色视频www国产| 亚洲精品亚洲一区二区| 久久久色成人| 熟女电影av网| 天天躁日日操中文字幕| 国产精品乱码一区二三区的特点| 欧美日韩中文字幕国产精品一区二区三区| 久久久久久久亚洲中文字幕 | 91av网一区二区| 国内精品久久久久久久电影| 麻豆久久精品国产亚洲av| 日韩亚洲欧美综合| 又紧又爽又黄一区二区| 欧美黑人巨大hd| 日本熟妇午夜| 日本a在线网址| 久久精品国产亚洲av涩爱 | 99久久九九国产精品国产免费| 亚洲美女视频黄频| 中文字幕精品亚洲无线码一区| 国产免费一级a男人的天堂| a级毛片a级免费在线| 色尼玛亚洲综合影院| 精品国产三级普通话版| 亚洲精品456在线播放app | 国产日本99.免费观看| 91字幕亚洲| 三级毛片av免费| 日韩免费av在线播放| 久久久色成人| 身体一侧抽搐| 久久久国产成人免费| 我的老师免费观看完整版| 欧美成狂野欧美在线观看| 久久香蕉精品热| 午夜福利在线观看吧| 国产乱人伦免费视频| 性色avwww在线观看| 欧美激情久久久久久爽电影| 中国美女看黄片| 人妻夜夜爽99麻豆av| 给我免费播放毛片高清在线观看| 91久久精品电影网| 精品无人区乱码1区二区| 久久国产乱子伦精品免费另类| 一卡2卡三卡四卡精品乱码亚洲| 日本黄大片高清| 亚洲18禁久久av| 免费一级毛片在线播放高清视频| 精品久久久久久久毛片微露脸| 99国产精品一区二区三区| 欧美zozozo另类| 中文亚洲av片在线观看爽| tocl精华| 日本与韩国留学比较| 亚洲avbb在线观看| 久久99热这里只有精品18| 国产欧美日韩精品一区二区| 噜噜噜噜噜久久久久久91| 欧美乱色亚洲激情| 国产精品久久久久久人妻精品电影| 亚洲成人免费电影在线观看| 精品欧美国产一区二区三| 午夜福利18| 国产v大片淫在线免费观看| 久久人人精品亚洲av| 精品久久久久久成人av| 99精品欧美一区二区三区四区| 中文字幕av在线有码专区| 99久久无色码亚洲精品果冻| 欧美日韩黄片免| 日本黄色片子视频| 久久精品国产清高在天天线| 男女那种视频在线观看| 国产精品自产拍在线观看55亚洲| 又黄又爽又免费观看的视频| 成年人黄色毛片网站| 久久欧美精品欧美久久欧美| 精品99又大又爽又粗少妇毛片 | 久久人妻av系列| a级毛片a级免费在线| 欧美不卡视频在线免费观看| 最后的刺客免费高清国语| 1000部很黄的大片| 欧美3d第一页| 岛国视频午夜一区免费看| 亚洲国产日韩欧美精品在线观看 | 免费无遮挡裸体视频| 久久久色成人| 日韩成人在线观看一区二区三区| 中文字幕人妻熟人妻熟丝袜美 | 少妇的逼水好多| 一夜夜www| 成人特级黄色片久久久久久久| 午夜激情福利司机影院| 搡女人真爽免费视频火全软件 | 成年免费大片在线观看| 亚洲人成网站在线播放欧美日韩| 99热6这里只有精品|